TherapeuticsMD, Inc. (NASDAQ:TXMD) Short Interest Down 29.9% in November

TherapeuticsMD, Inc. (NASDAQ:TXMD) was the target of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 21,100 shares, a decline of 29.9% from the November 15th total of 30,100 shares. Currently, 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 16,300 shares, the short-interest ratio is presently 1.3 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in TherapeuticsMD stock. Clearline Capital LP boosted its stake in shares of TherapeuticsMD, Inc. (NASDAQ:TXMD) by 18.9% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 636,622 shares of the company’s stock after purchasing an additional 101,282 shares during the period. Clearline Capital LP owned approximately 5.52% of TherapeuticsMD worth $1,025,000 at the end of the most recent quarter. Institutional investors and hedge funds own 30.74% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on TherapeuticsMD in a research report on Monday, December 9th. They issued a “hold” rating on the stock.

TherapeuticsMD Stock Down 2.4 %

Shares of TXMD stock traded down $0.03 during mid-day trading on Friday, reaching $1.22. The stock had a trading volume of 8,889 shares, compared to its average volume of 17,653. TherapeuticsMD has a 1-year low of $1.15 and a 1-year high of $2.75. The business’s fifty day moving average is $1.46 and its 200-day moving average is $1.68.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.